Chinese Journal of Tissue Engineering Research ›› 2011, Vol. 15 ›› Issue (21): 3913-3916.doi: 10.3969/j.issn.1673-8225.2011.21.026

Previous Articles     Next Articles

Polymer polyethylene membrane plasma separator in hyperlipemia: A 35-case analysis

Yu Ying, Meng Jian-zhong, Jing Ying, Wang Su-xia, Ge Yan-ming, Jia Feng-yu   

  1. Blood Purification Center, General Hospital of Jinan Military Area Command of Chinese PLA, Jinan   250031, Shandong Province, China
  • Received:2010-11-13 Revised:2010-12-30 Online:2011-05-21 Published:2011-05-21
  • About author:Yu Ying, Associate chief superintendent nurse, Blood Purification Center, General Hospital of Jinan Military Area Command of Chinese PLA, Jinan 250031, Shandong Province, China YUY2009@126.com

Abstract:

BACKGROUND: Blood lipid cleaning (BLC) can effectively reduce 50-70% of the level of cholesterol (CH), glycerin trilaurate (TG), low density lipoprotein (LDL), lipoprotein (a) and fibrinogen by double filtration plasmapheresis, without affecting the other components of plasma such as albumin, globulin, immune proteins, and electrolytes.
OBJECTIVE: To observe the effect of polyethylene membrane plasma separator and membrane plasma separator in the treatment of hyperlipidemia.
METHODS: A total of 35 cases of patiants with hyperlipemia were treated by BLC with polyethylene membrane plasma separator and membrane plasma separator. The operation of BLC machine, the use of anticoagulant dosage, blood, and immune outcome measures were performed according to operation procedure and corresponding monitoring data.
RESULTS AND CONCLUSION: The level of blood-fat was significantly reduced and the blood viscidity was lowered in 35 cases after treatment. The clinical symptoms such as drowsiness, insomnia, unfocused were visibly improved. Existing diabetes, hypertension and coronary disease were more easily controlled, including 5 cases of coronary heart disease was often accompanied by episodes of chest pain and chest tightness, and free of recurrence by BLC. Glucose was controlled preferably in 9 cases of diabetes after the treatment of BLC. It is indicated that the clinical effect of BLC with polyethylene membrane plasma separator and membrane plasma separator in the treatment of hyperlipemia was reliable, large sample test needs to be further verified.

CLC Number: